Chemotherapy has improved survival rates in patients with many of the common cancers. However, there is reliable evidence that, as a result of treatment, a subset of cancer survivors experience cognit READ MORE http://www.isdbweb.org/documents/file/4e6ef805a237b.pdf
Neurologic complications of chemotherapy have been reported with increasing frequency in cancer patients as a result of aggressive antineoplastic therapy with neurotoxic agents and prolonged patient s READ MORE http://www.medlink.com/subscribe_server.asp...
A subset of survivors has cognitive impairment after cancer treatment. This is generally subtle, but may be sustained. In October 2006, the second international cognitive workshop was held in Venice. READ MORE http://annonc.oxfordjournals.org/content/19/4/623.full
Background
Cancer treatment with a variety of chemotherapeutic agents often is associated with delayed adverse neurological consequences. Despite their clinical importance, almost nothing is known READ MORE http://jbiol.com/content/7/4/12
Some breast cancer survivors experience cognitive decline following chemotherapy. We prospectively examined changes in cognitive performance among high-risk breast cancer patients who had received hig READ MORE http://jnci.oxfordjournals.org/cgi/content/full/98/23/1742
Standard oncological therapies, such as chemotherapy and cranial radiotherapy, frequently result in a spectrum of neurocognitive deficits that includes impaired learning, memory, attention, and speed READ MORE http://theoncologist.com/cgi/content/full/13/12/1285